Literature DB >> 23386706

Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues.

Qiaoling Yao1, Mi-Kyung Shin, Jonathan C Jun, Karen L Hernandez, Neil R Aggarwal, Jason R Mock, Jason Gay, Luciano F Drager, Vsevolod Y Polotsky.   

Abstract

Chronic intermittent hypoxia (CIH) inhibits plasma lipoprotein clearance and adipose lipoprotein lipase (LPL) activity in association with upregulation of an LPL inhibitor angiopoietin-like protein 4 (Angptl4). We hypothesize that CIH inhibits triglyceride (TG) uptake via Angptl4 and that an anti-Angptl4-neutralizing antibody would abolish the effects of CIH. Male C57BL/6J mice were exposed to four weeks of CIH or intermittent air (IA) while treated with Ab (30 mg/kg ip once a week). TG clearance was assessed by [H(3)]triolein administration retroorbitally. CIH delayed TG clearance and suppressed TG uptake and LPL activity in all white adipose tissue depots, brown adipose tissue, and lungs, whereas heart, liver, and spleen were not affected. CD146+ CD11b- pulmonary microvascular endothelial cells were responsible for TG uptake in the lungs and its inhibition by CIH. Antibody to Angptl4 decreased plasma TG levels and increased TG clearance and uptake into adipose tissue and lungs in both control and CIH mice to a similar extent, but did not reverse the effects of CIH. The antibody reversed the effects of CIH on LPL in adipose tissue and lungs. In conclusion, CIH inactivates LPL by upregulating Angptl4, but inhibition of TG uptake occurs predominantly via an Angptl4/LPL-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23386706      PMCID: PMC3605982          DOI: 10.1194/jlr.M034272

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  71 in total

1.  Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metalloprotease-dependent process.

Authors:  Eva-Maria Boneberg; Harald Illges; Daniel F Legler; Gregor Fürstenberger
Journal:  Microvasc Res       Date:  2009-07-15       Impact factor: 3.514

2.  A stable, radioactive substrate emulsion for assay of lipoprotein lipase.

Authors:  P Nilsson-Ehle; M C Schotz
Journal:  J Lipid Res       Date:  1976-09       Impact factor: 5.922

Review 3.  The surfactant system and lung phospholipid biochemistry.

Authors:  S A Rooney
Journal:  Am Rev Respir Dis       Date:  1985-03

Review 4.  Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1.

Authors:  Laeticia Lichtenstein; Sander Kersten
Journal:  Biochim Biophys Acta       Date:  2010-01-06

5.  Vascular reactivity to norepinephrine and acetylcholine after chronic intermittent hypoxia in mice.

Authors:  C Julien; Sam Bayat; Bayat Sam; Patrick Lévy; Lévy Patrick
Journal:  Respir Physiol Neurobiol       Date:  2003-12-16       Impact factor: 1.931

6.  Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease.

Authors:  David M Smadja; Pascale Gaussem; Laetitia Mauge; Dominique Israël-Biet; Françoise Dignat-George; Séverine Peyrard; Gabriella Agnoletti; Pascal R Vouhé; Damien Bonnet; Marilyne Lévy
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

7.  Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).

Authors:  E-Chiang Lee; Urvi Desai; Gennady Gololobov; Seokjoo Hong; Xiao Feng; Xuan-Chuan Yu; Jason Gay; Nat Wilganowski; Cuihua Gao; Ling-Ling Du; Joan Chen; Yi Hu; Sharon Zhao; Laura Kirkpatrick; Matthias Schneider; Brian P Zambrowicz; Greg Landes; David R Powell; William K Sonnenburg
Journal:  J Biol Chem       Date:  2009-03-23       Impact factor: 5.157

Review 8.  Lipoprotein lipase: from gene to obesity.

Authors:  Hong Wang; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-24       Impact factor: 4.310

9.  Nonfasting triglycerides and risk of ischemic stroke in the general population.

Authors:  Jacob J Freiberg; Anne Tybjaerg-Hansen; Jan Skov Jensen; Børge G Nordestgaard
Journal:  JAMA       Date:  2008-11-12       Impact factor: 56.272

10.  Sleep-disordered breathing and mortality: a prospective cohort study.

Authors:  Naresh M Punjabi; Brian S Caffo; James L Goodwin; Daniel J Gottlieb; Anne B Newman; George T O'Connor; David M Rapoport; Susan Redline; Helaine E Resnick; John A Robbins; Eyal Shahar; Mark L Unruh; Jonathan M Samet
Journal:  PLoS Med       Date:  2009-08-18       Impact factor: 11.069

View more
  26 in total

Review 1.  Sleep Apnea Research in Animals. Past, Present, and Future.

Authors:  Swati Chopra; Vsevolod Y Polotsky; Jonathan C Jun
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

Review 2.  Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Christopher P O'Donnell; Sergio L Cravo; Geraldo Lorenzi-Filho; Benedito H Machado
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

Review 3.  Role of Angptl4 in vascular permeability and inflammation.

Authors:  Liang Guo; Shao-Ying Li; Fu-Yun Ji; Yun-Feng Zhao; Yu Zhong; Xue-Jun Lv; Xue-Ling Wu; Gui-Sheng Qian
Journal:  Inflamm Res       Date:  2013-10-31       Impact factor: 4.575

4.  Plasma and liver lipid profiles in rats exposed to chronic hypobaric hypoxia: changes in metabolic pathways.

Authors:  Patricia Siques; Julio Brito; Nelson Naveas; Ruth Pulido; Juan José De la Cruz; Maribel Mamani; Fabiola León-Velarde
Journal:  High Alt Med Biol       Date:  2014-09-03       Impact factor: 1.981

Review 5.  Chronic intermittent hypoxia exposure-induced atherosclerosis: a brief review.

Authors:  Dongmei Song; Guoqiang Fang; Harly Greenberg; Shu Fang Liu
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

6.  The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms.

Authors:  Diane Godin-Ribuot; Jan Polak; Anne Briançon-Marjollet; Martin Weiszenstein; Marion Henri; Amandine Thomas
Journal:  Diabetol Metab Syndr       Date:  2015-03-24       Impact factor: 3.320

Review 7.  Effects of Hyperoxia on Oxygen-Related Inflammation with a Focus on Obesity.

Authors:  Pedro González-Muniesa; Laura Garcia-Gerique; Pablo Quintero; Suyen Arriaza; Amaya Lopez-Pascual; J Alfredo Martinez
Journal:  Oxid Med Cell Longev       Date:  2015-12-01       Impact factor: 6.543

8.  Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation.

Authors:  Latt S Mansor; Keshavi Mehta; Dunja Aksentijevic; Carolyn A Carr; Trine Lund; Mark A Cole; Lydia Le Page; Maria da Luz Sousa Fialho; Michael J Shattock; Ellen Aasum; Kieran Clarke; Damian J Tyler; Lisa C Heather
Journal:  J Physiol       Date:  2015-12-20       Impact factor: 5.182

Review 9.  Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus.

Authors:  Preethi Rajan; Harly Greenberg
Journal:  Nat Sci Sleep       Date:  2015-10-05

10.  Effects of acute hypoxia on human adipose tissue lipoprotein lipase activity and lipolysis.

Authors:  Bimit Mahat; Étienne Chassé; Jean-François Mauger; Pascal Imbeault
Journal:  J Transl Med       Date:  2016-07-15       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.